New York Gaming Commission Approves Proposed Rule for Lasix List

By Matt Hegarty

Courtesy Daily Racing Form

The New York Gaming Commission on Tuesday approved the proposal of a rule that will ease requirements on horses going on and coming off the so-called Lasix list, in anticipation of Lasix-free racing being conducted at tracks in the state later this year.

The Lasix list is maintained by the state to track horses that can receive Lasix on race day, under the justification that the horse bled from the lungs one or more times during training or racing. The list requires horses to meet certain standards if they are taken off the list in order to be put back on, and those requirements could complicate efforts by New York tracks to run Lasix-free races this year.

Under the proposed rule, a trainer could request that a horse be allowed back on the list after running in a race in which raceday administrations of Lasix are prohibited. The New York Racing Association plans to ban the use of Lasix on race day in 2-year-old races held this year, and it also plans to expand the ban to all of its stakes races next year.

Under the existing regulations, if a horse runs in a race without Lasix, the trainer has to certify that a horse bled in a workout or race after having raced without the drug in order to be eligible to receive Lasix in its next race, in addition to other requirements.

The new rule also will allow the state steward at a New York track to remove a horse from the list to allow the horse to compete in a race in which Lasix is banned.

The gaming commission on Tuesday also approved a rule that will allow claims to be voided if a horse is judged lame in the test barn after a race, or if the horse suffers “epistaxis due to exercise-induced pulmonary hemmorrhage” as a result of the race. Epistaxis from EIPH is commonly defined as blood emerging from the nostrils due to bleeding in the lungs.

Current New York regulations already allow the voiding of claims if a horse is vanned off in a race. In all of the cases, trainers or owners are not required to void the claim, but can exercise that right under the three circumstances now on the books.

In other rule-making news:

* The NYGC adopted a rule prohibiting the intra-articular injections of corticosteroids within 14 days of a race. Racing jurisdictions across the United States are putting in place similar restrictions, on the guidance of an industry-funded group, the Racing Medication and Testing Consortium, and under the formulation of a model rule approved by the Association of Racing Commissioners International. The corticosteroid restriction also is being pushed by a group based in the Mid-Altantic seeking to reduce racehorse injuries. The NYGC is a member of that group.

* The NYGC adopted several provisions restricting use of non-steroidal inflammatory medications. NSAID use will now be limited to only three approved NSAIDs on the market – phenylbutazone, ketoprofen, and flunixin. In addition, only two of those three could be administered in a week prior to a race, as long as no NSAID is administered within 48 hours or a race, and the second is not administered within 96 hours of a race.

The NSAID rules also lowered the threshold levels for flunixin and phenylbutazone, consistent with regulations developed by the RMTC.

Leave a Reply

Your email address will not be published. Required fields are marked *